Chaim Lebovits - Apr 19, 2024 Form 4/A Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
President & CEO
Signature
/s/ Chaim Lebovits
Stock symbol
BCLI
Transactions as of
Apr 19, 2024
Transactions value $
$7,799
Form type
4/A
Date filed
7/31/2024, 04:06 PM
Date Of Original Report
Apr 25, 2024
Previous filing
Apr 19, 2024
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Purchase $7.8K +15K +1.78% $0.52 859K Apr 19, 2024 Direct F1
holding BCLI Common Stock 2M Apr 19, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 25, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.
F2 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.